| |
|
|
|
|
|
|
|
|
 |
 |
|
|
|
|
| Audience |
|
Nursing:
Hematological Disorders
|
| Authors |
Kathleen Schutta, MSN, CFNP
Kathleen M Schutta, MSN, CFNP |
| Hours |
3.00 contact hours |
| Expires |
EXPIRED |
|
|
| Passing Grade |
70% |
| Test Retries |
Unlimited
|
|
|
|
After completion of this course the participant should be able to:
- Differentiate between sickle cell trait and sickle cell anemia.
- Identify the difference between a normal red blood cell and a sickled red blood cell.
- Explain how polymerization causes sickling.
- State how vaso-occlusion and hemolytic anemia contribute to sickle cell crises.
- Recognize the role of fetal hemoglobin in sickle cell anemia.
- Identify the signs and symptoms of an aplastic crisis, splenic sequestration, sepsis, and vaso-occlusive/pain crisis.
- Describe the appropriate treatment for an aplastic crisis, splenic sequestration, sepsis, and vaso-occlusive/pain crisis.
- Differentiate several treatment options that are available to prevent sickle cell crises.
- Select an appropriate preventative treatment for a patient with sickle cell anemia.
- Discuss the age-related differences of morbidity and mortality in sickle cell anemia patients.
|
|
|
|
|
|
|
|
To take just this course, test, and evaluation and get your certificate online, the cost is only $ 45.00!
| Hours |
Price |
p/Hour |
Discount |
| 10 |
$ 142 |
$ 14.20 |
5% off! |
| 15 |
$ 203 |
$ 13.53 |
10% off! |
| 20 |
$ 257 |
$ 12.85 |
14% off! |
| 25 |
$ 302 |
$ 12.08 |
19% off! |
| 30 |
$ 339 |
$ 11.30 |
25% off! |
| 35 |
$ 367 |
$ 10.49 |
30% off! |
| 40 |
$ 386 |
$ 9.65 |
36% off! |
| 45 |
$ 405 |
$ 9.00 |
40% off! |
Hours purchased are good for an unlimited time, but only within the discipline they were purchased in.
(If located in Ohio state taxes will be applied before purchase)
|
|
|
|
|
|
|
No Commercial Support or Sponsorship is accepted by CEU4U, Inc.
Products, drugs, and/or therapies discussed within this educational offering do NOT imply endorsement by CEU4U, Inc. or American Nurses Credentialing Center.
No off label use of product(s) are discussed in this educational offering.
The author(s) and planning committee of this content declare that they have no real or perceived conflict of interest related to this presentation.
|
Course Sample:
[A glossary of terms is included at the end of the course for the user?s convenience.] Introduction Sickle cell disease is a group of genetically inherited disorders of hemoglobin structure. In sickle cell disease, there is an amino-acid substitution of valine for glutamic acid in the sixth position of the ß-globin chain, which results in the formation of the hemoglobin S gene (Hillman & Ault 1998). Sickle cell anemia occurs when a person inherits two hemoglobin S genes, one from each parent, and is called homozygous sickle cell disease or Hb SS. The coinheritance of one hemoglobin S gene with another abnormal hemoglobin gene, such as hemoglobin C, hemoglobin D, or ß-thalassemia, can cause variations in the clinical presentation and severity of the disease. People who inherit one hemoglobin S gene and one normal hemoglobin A gene have the sickle cell trait and are asymptomatic, but can pass the hemoglobin S gene on to future generations. This course will focus on sickle cell anemia, or homozygous sickle cell disease (Hb SS). HISTORY Thousands of years ago, a deadly form of malaria was common in Africa, the Middle East, India, and some Mediterranean countries. A survival advantage was seen in those children who inherited one sickle hemoglobin gene, and thus carried the sickle cell trait. These children passed the mutated sickle hemoglobin gene on to future generations. As populations migrated, the mutation spread. In countries where malaria was not a problem, the mutated sickle hemoglobin gene no longer provided any benefit, and instead posed a serious threat to the well-being of the carrier?s children, some of whom inherited two mutated sickle hemoglobin genes, one from each parent, and developed sickle cell anemia (NHLBI 1996). PREVALENCE & GEOGRAPHIC DISTRIBUTION Throughout the world, millions of people are affected by sickle cell disease. It is found most often in people whose ancestors are from Africa, Saudi Arabia, India, South America, Turkey, Greece, and Italy. Approximately 72,000 people in the United States have sickle cell anemia, most of whom are African-American. It is estimated that 1 in every 500 African-Americans has the disease, and 1 in 12 carries the sickle cell trait (NHLBI 1996). PATHOPHYSIOLOGY |
|
|
|
|
|
|
|
